» Articles » PMID: 23757435

Aldosterone, C-reactive Protein, and Plasma B-type Natriuretic Peptide Are Associated with the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components: Findings from the Jackson Heart Study

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2013 Jun 13
PMID 23757435
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Several pathomechanisms are implicated in the pathogenesis of metabolic syndrome (MetS), most of which have not been investigated in African Americans (AAs). We examined the contribution of a selected panel of biomarkers to the development of MetS in Jackson Heart Study (JHS) participants in this investigation.

Research Design And Methods: We evaluated 3,019 JHS participants (mean age, 54 years; 64% women) with measurements for seven biomarkers representing inflammation (high-sensitivity C-reactive protein [CRP]), adiposity (leptin), natriuretic pathway (B-natriuretic peptide [BNP]), adrenal pathway (cortisol and aldosterone), and endothelial function (endothelin and homocysteine). We related the biomarker panel to the development of MetS on follow-up and to longitudinal changes in MetS components.

Results: There were 278 (22.9%) of 1,215 participants without MetS at baseline who had development of new-onset MetS at follow-up. The incidence of MetS was significantly associated with serum aldosterone (P=0.004), CRP (P=0.03), and BNP (P for trend=0.005). The multivariable-adjusted odds ratios (95% CI) per SD increment of log biomarker were as follows: 1.25 (1.07-1.45) for aldosterone, 1.20 (1.02-1.43) for CRP, and 1.54 (1.07-2.23) and 1.91 (1.31-2.80) for low and high BNP quartiles, respectively. Aldosterone was positively associated with change in all MetS risk components, except low HDL cholesterol and waist circumference. CRP concentration was significantly and directly associated with change in systolic blood pressure (SBP) and waist circumference but inversely associated with HDL cholesterol. For BNP, we observed a U-shape relation with SBP and triglycerides.

Conclusions: Our analysis confirms that, in AAs, higher circulating aldosterone and CRP concentrations predict incident MetS. The nonlinear U-shape relation of BNP with MetS and its components has not been reported before and thus warrants replication.

Citing Articles

The association between aldosterone and lipid profiles in patients with primary aldosteronism.

Liang N, Rao K, Hu M, Bao R, Liu J, Lai Z Sci Rep. 2025; 15(1):8755.

PMID: 40082504 PMC: 11906652. DOI: 10.1038/s41598-025-92477-9.


Association of baseline and changes in adiponectin, homocysteine, high-sensitivity C-reactive protein, interleukin-6, and interleukin-10 levels and metabolic syndrome incidence: Tehran lipid and glucose study.

Zahedi A, Daneshpour M, Akbarzadeh M, Hedayati M, Azizi F, Zarkesh M Heliyon. 2023; 9(9):e19911.

PMID: 37809533 PMC: 10559325. DOI: 10.1016/j.heliyon.2023.e19911.


The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study.

Joseph J, Kluwe B, Zhao S, Kline D, Nedungadi D, Brock G Endocr Metab Sci. 2023; 11.

PMID: 37475850 PMC: 10358435. DOI: 10.1016/j.endmts.2023.100128.


Adiposity, aldosterone and plasma renin activity among African Americans: The Jackson Heart Study.

Lee G, Kluwe B, Zhao S, Kline D, Nedungadi D, Brock G Endocr Metab Sci. 2023; 11.

PMID: 37475849 PMC: 10358448. DOI: 10.1016/j.endmts.2023.100126.


Inflammation as a therapeutic target in heart failure with preserved ejection fraction.

Peh Z, Dihoum A, Hutton D, Arthur J, Rena G, Khan F Front Cardiovasc Med. 2023; 10:1125687.

PMID: 37456816 PMC: 10339321. DOI: 10.3389/fcvm.2023.1125687.


References
1.
Albert M, Glynn R, Buring J, Ridker P . C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004; 93(10):1238-42. DOI: 10.1016/j.amjcard.2004.01.067. View

2.
Ridker P . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107(3):363-9. DOI: 10.1161/01.cir.0000053730.47739.3c. View

3.
Birkenfeld A, Boschmann M, Moro C, Adams F, Heusser K, Franke G . Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab. 2005; 90(6):3622-8. DOI: 10.1210/jc.2004-1953. View

4.
Reilly M, Wolfe M, Rhodes T, Girman C, Mehta N, Rader D . Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation. 2004; 110(7):803-9. DOI: 10.1161/01.CIR.0000138740.84883.9C. View

5.
Ingelsson E, Pencina M, Tofler G, Benjamin E, Lanier K, Jacques P . Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation. 2007; 116(9):984-92. DOI: 10.1161/CIRCULATIONAHA.107.708537. View